{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T23:15:32Z","timestamp":1767827732660,"version":"3.49.0"},"reference-count":80,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2011,6,10]],"date-time":"2011-06-10T00:00:00Z","timestamp":1307664000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0020705","type":"journal-article","created":{"date-parts":[[2011,6,17]],"date-time":"2011-06-17T20:19:34Z","timestamp":1308341974000},"page":"e20705","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":27,"title":["Subtype Specific Elevated Expression of Hyaluronidase-1 (HYAL-1) in Epithelial Ovarian Cancer"],"prefix":"10.1371","volume":"6","author":[{"given":"Paule H\u00e9l\u00e9na","family":"Yoffou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lydia","family":"Edjekouane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liliane","family":"Meunier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9","family":"Tremblay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane Mich\u00e8le","family":"Provencher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Marie","family":"Mes-Masson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Euridice","family":"Carmona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2011,6,10]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3322\/CA.2007.0010","article-title":"Cancer statistics, 2008.","volume":"58","author":"A Jemal","year":"2008","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1056\/NEJM200503243521222","article-title":"Cancer of the ovary.","volume":"352","author":"CM Liu","year":"2005","journal-title":"N Eng J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1146\/annurev.pathol.4.110807.092246","article-title":"Ovarian cancer.","volume":"4","author":"KR Cho","year":"2009","journal-title":"Annu Rev Pathol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/01.pgp.0000101080.35393.16","article-title":"The histologic type and stage distribution of ovarian carcinomas of surface epithelial origin.","volume":"23","author":"JD Seidman","year":"2004","journal-title":"Int J Gynecol Pathol"},{"key":"ref5","first-page":"3378","article-title":"Ovarian carcinoma develops through multiple modes of chromosomal evolution.","volume":"63","author":"M Hoglund","year":"2003","journal-title":"Cancer Res"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1101\/gr.174202","article-title":"Expression profiles of 290 ESTs mapped to chromosome 3 in human epithelial ovarian cancer cell lines using DNA expression oligonucleotide microarrays.","volume":"12","author":"EN Manderson","year":"2002","journal-title":"Genome Res"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/mc.20361","article-title":"Transcriptome analysis of serous ovarian cancers identifies differentially expressed chromosome 3 genes.","volume":"47","author":"AH Birch","year":"2008","journal-title":"Mol Carcinog"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"5719","DOI":"10.1038\/sj.onc.1207760","article-title":"Discovery of frequent homozygous deletions in chromosome 3p21.3 LUCA and AP20 regions in renal, lung and breast carcinomas.","volume":"23","author":"VN Senchenko","year":"2004","journal-title":"Oncogene"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0945-053X(01)00172-X","article-title":"The six hyaluronidase-like genes in the human and mouse genomes.","volume":"20","author":"AB Csoka","year":"2001","journal-title":"Matrix Biol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"18028","DOI":"10.1073\/pnas.0506825102","article-title":"Identification of a hyaluronidase, Hyal5, involved in penetration of mouse sperm through cumulus mass.","volume":"102","author":"E Kim","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1006\/geno.1999.5876","article-title":"Expression analysis of six paralogous human hyaluronidase genes clustered on chromosomes 3p21 and 7q31.","volume":"60","author":"AB Csoka","year":"1999","journal-title":"Genomics"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.mce.2005.12.033","article-title":"Epididymal SPAM1 and its impact on sperm function.","volume":"250","author":"PA Martin-DeLeon","year":"2006","journal-title":"Mol Cell Endocrinol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.ejcb.2006.05.009","article-title":"Hyaluronan fragments: an information-rich system.","volume":"85","author":"R Stern","year":"2006","journal-title":"Eur J Cell Biol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/glycob\/cwn006","article-title":"Mouse Hyal-3 encodes a 45\u201356 kDa glycoprotein whose overexpression increases hyaluronidase 1 activity in cultured cells.","volume":"18","author":"R Hemming","year":"2008","journal-title":"Glycobiology"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/ijc.11733","article-title":"A Genetic alterations in the peritumoral stromal cells of malignant and borderline epithelial ovarian tumors as indicated by allelic imbalance on chromosome 3p.","volume":"109","author":"H Tuhkanen","year":"2004","journal-title":"Int J Cancer"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/1471-2407-9-143","article-title":"Expression of hyaluronan synthases (HAS1\u20133) and hyaluronidases (HYAL1\u20132) in serous ovarian carcinomas: inverse correlation between HYAL1 and hyaluronan content.","volume":"9","author":"TK Nykopp","year":"2009","journal-title":"BMC Cancer"},{"key":"ref17","first-page":"6410","article-title":"Elevated hyaluronan concentration without hyaluronidase activation in malignant epithelial ovarian tumors.","volume":"62","author":"EL Hiltunen","year":"2002","journal-title":"Cancer Res"},{"key":"ref18","first-page":"150","article-title":"High levels of stromal hyaluronan predict poor disease outcome in epithelial ovarian cancer.","volume":"60","author":"MA Anttila","year":"2000","journal-title":"Cancer Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.semcancer.2008.03.007","article-title":"Hyaluronan-mediated CD44 activation of RhoGTPase signalling and cytoskeleton function promotes tumor progression.","volume":"18","author":"LY Bourguignon","year":"2008","journal-title":"Semin Cancer Biol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/ijc.11252","article-title":"Expression of tumor markers hyaluronic acid and hyaluronidase (HYAL1) in head and neck tumors.","volume":"106","author":"EJ Franzmann","year":"2003","journal-title":"Int J Cancer"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0022-5347(05)68050-0","article-title":"Urinary hyaluronic acid and hyaluronidase: markers for bladder cancer detection and evaluation of grade.","volume":"163","author":"VB Lokeshwar","year":"2000","journal-title":"J Urol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.semcancer.2008.03.008","article-title":"Hyaluronidase: both a tumor promoter and suppressor. Review.","volume":"18","author":"VB Lokeshwar","year":"2008","journal-title":"Semin Cancer Biol"},{"key":"ref23","first-page":"2423","article-title":"Freger P. Hyaluronidase is more elevated in human brain metastases than in primary brain tumours.","volume":"22","author":"B Delpech","year":"2002","journal-title":"Anticancer Res"},{"key":"ref24","first-page":"1300","article-title":"Comparison of hyaluronidase expression, invasiveness and tubule formation in ER(\u2212) and ER(+) breast cancer cell lines in vitro.","volume":"122","author":"X-Y Wang","year":"2009","journal-title":"Chin Med J (Engl)"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0304-3835(00)00669-8","article-title":"Plasma hyaluronidase (Hyal-1) promotes tumor cell cycling.","volume":"163","author":"G Lin","year":"2001","journal-title":"Cancer Lett"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"7782","DOI":"10.1158\/0008-5472.CAN-05-1022","article-title":"HYAL1 hyaluronidase in prostate cancer: a tumor promoter and suppressor.","volume":"65","author":"VB Lokeshwar","year":"2005","journal-title":"Cancer Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1158\/0008-5472.CAN-04-2805","article-title":"HYAL1 hyaluronidase: a molecular determinant of bladder tumor growth and invasion.","volume":"65","author":"VB Lokeshwar","year":"2005","journal-title":"Cancer Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"24195","DOI":"10.1074\/jbc.M411913200","article-title":"Hyaluronan fragments induce endothelial cell differentiation in a CD44- and CXCL1\/GRO1-dependent manner.","volume":"280","author":"Y Takahashi","year":"2005","journal-title":"J Biol Chem"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1006\/excr.1994.1346","article-title":"Primary cultures of normal and tumoral human ovarian epithelium: a powerful tool for basic molecular studies.","volume":"215","author":"H Lounis","year":"1994","journal-title":"Exp Cell Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1290\/1071-2690(2000)036<0357:COFNEO>2.0.CO;2","article-title":"Characterization of four novel epithelial ovarian cancer cell lines.","volume":"36","author":"DM Provencher","year":"2000","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1471-2407-8-152","article-title":"Characterization of three new serous epithelial ovarian cancer cell lines.","volume":"8","author":"V Ouellet","year":"2008","journal-title":"BMC Cancer"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1101\/gr.174202","article-title":"Expression profiles of 290 ESTs mapped to chromosome 3 in human epithelial ovarian cancer cell lines using DNA expression oligonucleotide microarrays.","volume":"12","author":"EN Manderson","year":"2002","journal-title":"Genome Research"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/pros.20929","article-title":"Quantitative RT-PCR analysis of estrogen receptor gene expression in laser microdissected prostate cancer tissue.","volume":"69","author":"TJ Walton","year":"2009","journal-title":"The Prostate"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"4672","DOI":"10.1038\/sj.onc.1208214","article-title":"Discrimination between serous low malignant potential and invasive epithelial ovarian tumors using molecular profiling.","volume":"24","author":"V Ouellet","year":"2005","journal-title":"Oncogene"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ccr.2007.02.016","article-title":"Mouse model of human ovarian endometrioid adenocarcinoma based on somatic defects in the Wnt\/beta-catenin and PI3K\/Pten signaling pathways.","volume":"11","author":"R Wu","year":"2007","journal-title":"Cancer Cell"},{"key":"ref36","first-page":"6367","article-title":"PDZK1 and GREB1 are estrogen-regulated genes expressed in hormone-responsive breast cancer.","volume":"60","author":"MG Ghosh","year":"2000","journal-title":"Cancer Res"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/oxfordjournals.jbchem.a123014","article-title":"Complete primary structure of the human estrogen-responsive gene (pS2) product.","volume":"107","author":"K Mori","year":"1990","journal-title":"J Biochem"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"5835","DOI":"10.1210\/en.2008-0175","article-title":"Mammalian hyaluronidase induces ovarian granulosa cell apoptosis and is involved in follicular atresia.","volume":"149","author":"AM Orimoto","year":"2008","journal-title":"Endocrinology"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0021-9258(18)65959-9","article-title":"A modified colorimetric method for the estimation of N-acetylamino sugars.","volume":"217","author":"JL Reissig","year":"1955","journal-title":"J Biol Chem"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/jcla.20285","article-title":"Effect of anticoagulants on the plasma hyaluronidase activities.","volume":"23","author":"R Sharma","year":"2009","journal-title":"J Clin Lab Anal"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"4830","DOI":"10.1074\/jbc.M607908200","article-title":"The hormonal response of estrogen receptor beta is decreased by the phosphatidylinositol 3- kinase\/Akt pathway via a phosphorylation-dependent release of CREB-binding protein.","volume":"282","author":"M Sanchez","year":"2007","journal-title":"J Biol Chem"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"5793","DOI":"10.1158\/0008-5472.CAN-08-4924","article-title":"Positive feedback activation of estrogen receptors by the CXCL12-CXCR4 pathway.","volume":"69","author":"K Sauv\u00e9","year":"2009","journal-title":"Cancer Res"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/0003-9861(67)90598-X","article-title":"The existence of an acid-active hyaluronidase in serum.","volume":"120","author":"M De Salegui","year":"1967","journal-title":"Arch Biochem Biophys"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0248-4900(90)90293-C","article-title":"Polymorphism of hyaluronidase in serum from man, various mouse strains and other vertebrate species revealed by electrophoresis.","volume":"68","author":"B Fiszer-Szafarz","year":"1990","journal-title":"Biol Cell"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/jnci\/94.1.32","article-title":"Impact of progestin and estrogen potency in oral contraceptives on ovarian cancer risk.","volume":"94","author":"JM Schildkraut","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/01.AOG.0000154152.12088.48","article-title":"Androgenic progestins in oral contraceptives and the risk of epithelial ovarian cancer.","volume":"105","author":"JB Greer","year":"2005","journal-title":"Obstet Gynecol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1001\/jama.288.3.334","article-title":"Menopausal hormone replacement therapy and risk of ovarian cancer.","volume":"288","author":"JV Lacey Jr","year":"2002","journal-title":"JAMA"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1001\/jama.2009.1052","article-title":"Hormone therapy and ovarian cancer.","volume":"302","author":"LS M\u00f8rch","year":"2009","journal-title":"JAMA"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ygyno.2004.11.010","article-title":"Expression of progesterone receptor is a favourable prognostic marker in ovarian cancer.","volume":"96","author":"P Lee","year":"2005","journal-title":"Gynecol Oncol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/01.AOG.0000296715.07705.e9","article-title":"Estrogen receptor subtypes in ovarian cancer: a clinical correlation.","volume":"111","author":"KK Chan","year":"2008","journal-title":"Obstet Gynecol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1477-7827-1-73","article-title":"Estrogen, progesterone and epithelial ovarian cancer.","volume":"1","author":"SM Ho","year":"2003","journal-title":"Reprod Biol Endocrinol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1002\/med.20131","article-title":"Estrogen and its receptors in cancer.","volume":"28","author":"GG Chen","year":"2008","journal-title":"Med Res Rev"},{"key":"ref53","first-page":"48","article-title":"Expression of the estrogen and progesterone receptors as prognostic factor in serous ovarian cancers.","volume":"31","author":"LG Buchynska","year":"2009","journal-title":"Exp Oncol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1046\/j.1365-2559.2001.01042.x","article-title":"Precursor lesions of ovarian epithelial malignancy.","volume":"38","author":"KM Feeley","year":"2001","journal-title":"Histopathology"},{"key":"ref55","first-page":"567","article-title":"Major oncogenes and tumor suppressor genes involved in epithelial ovarian cancer.","volume":"16","author":"B Aunoble","year":"2000","journal-title":"Int J Oncol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1002\/1097-0142(20000601)88:11<2584::AID-CNCR22>3.0.CO;2-5","article-title":"Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy.","volume":"88","author":"T Sugiyama","year":"2000","journal-title":"Cancer"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ygyno.2005.12.038","article-title":"Advanced stage clear-cell epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience.","volume":"102","author":"D Pectasides","year":"2006","journal-title":"Gynecologic Oncology"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1200\/JCO.2004.08.078","article-title":"Mucinous epithelial ovarian cancer: a separate entity requiring specific treatment.","volume":"22","author":"V Hess","year":"2004","journal-title":"J Clin Oncol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.ygyno.2006.08.023","article-title":"Recommendations of the 2005 Ovarian Cancer State of the Science Meeting.","volume":"103","author":"EL Trimble","year":"2006","journal-title":"Gynecologic Oncology"},{"key":"ref60","first-page":"1535","article-title":"Role of tumour markers in monitoring epithelial ovarian cancer.","volume":"9","author":"T Meyer","year":"2000","journal-title":"Br J Cancer"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/gcc.2870040108","article-title":"Chromosome aberrations in 35 primary ovarian carcinomas.","volume":"4","author":"T Pejovic","year":"1992","journal-title":"Genes Chromosomes Cancer"},{"key":"ref62","first-page":"2765","article-title":"Chromosomal imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasms.","volume":"57","author":"F Mertens","year":"1997","journal-title":"Cancer Res"},{"key":"ref63","first-page":"542","article-title":"Human Semaphorin 3B (SEMA3B) located at chromosome 3p21.3 suppresses tumor formation in an adenocarcinoma cell line.","volume":"62","author":"C Tse","year":"2002","journal-title":"Cancer Res"},{"key":"ref64","first-page":"2637","article-title":"Semaphorin 3F gene from human 3p21.3 suppresses tumor formation in nude mice.","volume":"62","author":"R Xiang","year":"2002","journal-title":"Cancer Res"},{"key":"ref65","first-page":"58","article-title":"The Ras-association domain family (RASSF) members and their role in human tumourigenesis.","volume":"1776","author":"L van der Weyden","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1242\/jcs.010389","article-title":"The RASSF1A tumor suppressor.","volume":"120","author":"H Donninger","year":"2007","journal-title":"J Cell Sci"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.humpath.2009.04.017","article-title":"Ovarian carcinoma pathology and genetics: recent advances.","volume":"40","author":"CB Gilks","year":"2009","journal-title":"Human Pathology"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.semcancer.2008.03.009","article-title":"Hyaluronan: A constitutive regulator of chemoresistance and malignancy in cancer cells.","volume":"18","author":"BP Toole","year":"2008","journal-title":"Semin Cancer Biol"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.semcancer.2008.03.005","article-title":"Hyaluronan in human tumors: Pathobiological and prognostic messages from cell-associated and stromal hyaluronan.","volume":"18","author":"RH Tammi","year":"2008","journal-title":"Semin Cancer Biol"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.semcancer.2008.03.014","article-title":"Association between cancer and \u201cmucopolysaccharides\u201d: An old concept comes of age, finally.","volume":"18","author":"R Stern","year":"2008","journal-title":"Semin Cancer Biol"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"31","DOI":"10.18388\/abp.1995_4663","article-title":"Hyaluronidase in human somatic tissues and urine: polymorphism and the activity in diseases.","volume":"42","author":"B Fiszer-Szafarz","year":"1995","journal-title":"Acta Biochim Pol"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1002\/ijc.21521","article-title":"From gene profiling to diagnostic markers: IL-18 and FGF-2 complement CA125 as serum-based markers in epithelial ovarian cancer.","volume":"118","author":"C Le Page","year":"2006","journal-title":"Int J Cancer"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1158\/1055-9965.EPI-07-0692","article-title":"BTF4\/BTNA3.2 and GCS as candidate mRNA prognostic markers in epithelial ovarian cancer.","volume":"17","author":"C Le Page","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0303-7207(00)00340-3","article-title":"Expression and actions of both the follicle stimulating hormone receptor and the luteinizing hormone receptor in normal ovarian surface epithelium and ovarian cancer.","volume":"172","author":"JA Parrott","year":"2001","journal-title":"Mol Cell Endocrinol"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1210\/er.2006-0036","article-title":"Gonadotropins and ovarian cancer.","volume":"28","author":"JH Choi","year":"2007","journal-title":"Endocr Rev"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.mce.2010.04.028","article-title":"Are gonadotrophins tumorigenic-A critical review of clinical and experimental data.","volume":"329","author":"I Huhtaniemi","year":"2010","journal-title":"Mol Cell Endocrinol"},{"key":"ref77","first-page":"161","article-title":"Histologic subtypes of ovarian carcinoma: an overview.","volume":"27","author":"RA Soslow","year":"2008","journal-title":"Int J Gynecol Pathol"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s10147-008-0818-7","article-title":"Current research topics in endocrine therapy for breast cancer.","volume":"13","author":"H Yamashita","year":"2008","journal-title":"Int J Clin Oncol"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/ijc.25460","article-title":"HYAL1 over-expression is correlated with the malignant behavior of human breast cancer.","volume":"128","author":"JX Tan","year":"2011","journal-title":"Int J Cancer"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"11961","DOI":"10.1074\/jbc.M411985200","article-title":"Hyaluronan-CD44 interaction with IQGAP1 promotes Cdc42 and ERK signaling, leading to actin binding, Elk-1\/estrogen receptor transcriptional activation, and ovarian cancer progression.","volume":"280","author":"LY Bourguignon","year":"2005","journal-title":"J Biol Chem"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0020705","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T12:50:50Z","timestamp":1637844650000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0020705"}},"subtitle":[],"editor":[{"given":"Nai Sum","family":"Wong","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2011,6,10]]},"references-count":80,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2011,6,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0020705","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,10]]}}}